Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat

Life Sciences

Volumn 73, Issue 4, 2003, Pages 487-498

  Tóth, Attila ^a   Kedei, Noémi ^a   Wang, Yun ^a   Blumberg, Peter M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

45Ca2+ uptake; Anandamide; Antagonism; Arachidonyl dopamine; Capsaicin; Desensitization; Intracellular Ca2+ imaging; Resiniferatoxin (RTX) binding; Vanilloid receptor subtype 1 (VR1); VR1 transfected CHO cells (CHO VR1)

Indexed keywords

ANANDAMIDE; ARACHIDONYLDOPAMINE; CAPSAICIN; LIGAND; RECEPTOR SUBTYPE; RESINIFERATOXIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CHO CELL; CONCENTRATION RESPONSE; EMBRYO; HUMAN; HUMAN CELL; IC 50; LIGAND BINDING; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SPINAL CORD;

ANIMALIA;

EID: 0038636006     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00310-2     Document Type: Article

References (25)

1. Bisogno T., Melck D., Bobrov M.Y., Gretskaya N.M., Bezuglov V.V., De Petrocellis L., Di Marzo V. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J. 351:2000;817-824.
2. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 389:1997;816-824.
3. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 288:2000;306-313.
4. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
5. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., Zimmer A., Martin B.R. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J Neurochem. 75:2000;2434-2444.
6. Di Marzo V., Bisogno T., De Petrocellis L. Anandamide: some like it hot. Trends Pharmacol Sci. 22:2001;346-349.
7. Di Marzo V., Blumberg P.M., Szallasi A. Endovanilloid signaling in pain. Curr Opin Neurobiol. 12:2002;372-379.
8. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A., Bisogno T. Anandamide receptors. Prostaglandins Leukot Essent Fatty Acids. 66:2002;377-391.
9. Howlett A.C., Mukhopadhyay S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids. 108:2000;53-70.
10. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker J.M., Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A. 99:2002;8400-8405.
11. Hwang S.W., Cho H., Kwak J., Lee S.Y., Kang C.J., Jung J., Cho S., Min K.H., Suh Y.G., Kim D., Oh U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A. 97:2000;6155-6160.
12. Kedei N., Szabo T., Lile J.D., Treanor J.J., Olah Z., Iadarola M.J., Blumberg P.M. Analysis of the native quaternary structure of vanilloid receptor 1. J Biol Chem. 276:2001;28613-28619.
13. Koplas P.A., Rosenberg R.L., Oxford G.S. The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J Neurosci. 17:1997;3525-3537.
14. Liu L., Simon S.A. The influence of removing extracellular Ca2+ in the desensitization responses to capsaicin, zingerone and olvanil in rat trigeminal ganglion neurons. Brain Res. 809:1998;246-252.
15. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A. 97:2000;3655-3660.
16. Olah Z., Szabo T., Karai L., Hough C., Fields R.D., Caudle R.M., Blumberg P.M., Iadarola M.J. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem. 276(14):2001;11021-11030.
17. Premkumar L.S., Ahern G.P. Induction of vanilloid receptor channel activity by protein kinase C. Nature. 408:2000;985-990.
18. Robbins W. Clinical applications of capsaicinoids. Clin J Pain. 16:2000;S86-S89.
19. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol. 129:2000;227-230.
20. Szallasi A., Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev. 51:1999;159-212.
21. Szolcsanyi J. Anandamide and the question of its functional role for activation of capsaicin receptors. Trends Pharmacol Sci. 21:2000;203-204.
22. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 21:1998;531-543.
23. Toth A., Kedei N., Szabo T., Wang Y., Blumberg P.M. Thapsigargin binds to and inhibits the cloned vanilloid receptor-1. Biochem Biophys Res Commun. 293:2002;777-782.
24. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.
25. Zygmunt P.M., Julius I., Di Marzo I., Hogestatt E.D. Anandamide - the other side of the coin. Trends Pharmacol Sci. 21:2000;43-44.